CYTORI THERAPEUTICS INC - COM (CYTX)

CUSIP: 23283K105

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Equity / COM
Total 13F shares
19,982,729
Share change
+2,651,629
Total reported value
$13,517,595
Put/Call ratio
171%
Price per share
$0.68
Number of holders
66
Value change
+$1,567,961
Number of buys
25
Number of sells
32

Quarterly Holders Quick Answers

What is CUSIP 23283K105?
CUSIP 23283K105 identifies CYTX - CYTORI THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CYTORI THERAPEUTICS INC - COM (CYTX) as of Q3 2014

As of 30 Sep 2014, CYTORI THERAPEUTICS INC - COM (CYTX) was held by 66 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,982,729 shares. The largest 10 holders included SABBY MANAGEMENT, LLC, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, BlackRock Fund Advisors, GOLDMAN CAPITAL MANAGEMENT INC, MARATHON CAPITAL MANAGEMENT, State Street Corp, NORTHERN TRUST CORP, PERKINS CAPITAL MANAGEMENT INC, and RENAISSANCE TECHNOLOGIES LLC. This page lists 66 institutional shareholders reporting positions in this security for the Q3 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.